BLACK DIAMOND THERAPEUTICS

black-diamond-therapeutics-logo

Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery and development of small-molecule. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform namely, Mutation-Allostery-Pharmacology which is targeting mutations in cancer. Black Diamond focused on the discovery and development of precision medicines for cancer that is directed against a novel class of allosteric mutant oncogenes. The company targets undrugged mutations in patients with genetically defined cancers for whom limited treatment options currently exist. It is built upon a deep understanding of cancer genetics, protein structure and function, and medicinal chemistry.
#SimilarOrganizations #People #Financial #Event #Website #More

BLACK DIAMOND THERAPEUTICS

Social Links:

linkedin

Linkedin

Industry:
Biotechnology Life Science Medical

Founded:
2017-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.blackdiamondtherapeutics.com

Total Employee:
11+

Status:
Active

Contact:
617-417-5868

Email Addresses:
[email protected]

Total Funding:
197.1 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Nginx Microsoft Exchange Online Organization Schema Office 365 Mail IPv6


Similar Organizations

acrivon-therapeutics-logo

Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.


Current Advisors List

samarth-kulkarni_image

Samarth Kulkarni Board Member @ Black Diamond Therapeutics
Board_member
2019-12-01

Current Employees Featured

david-m-epstein_image

David M. Epstein
David M. Epstein Founder, President & Chief Executive Officer @ Black Diamond Therapeutics
Founder, President & Chief Executive Officer

alexander-mayweg_image

Alexander Mayweg
Alexander Mayweg Founding, Chief Scientific Officer @ Black Diamond Therapeutics
Founding, Chief Scientific Officer

christopher-roberts_image

Christopher Roberts
Christopher Roberts Chief Scientific Officer @ Black Diamond Therapeutics
Chief Scientific Officer

sergey-yurasov_image

Sergey Yurasov
Sergey Yurasov Chief Medical Officer @ Black Diamond Therapeutics
Chief Medical Officer
2022-06-01

elizabeth-montgomery_image

Elizabeth Montgomery
Elizabeth Montgomery Chief People Officer @ Black Diamond Therapeutics
Chief People Officer
2022-02-01

elizabeth-buck_image

Elizabeth Buck
Elizabeth Buck Founder, Executive Vice President @ Black Diamond Therapeutics
Founder, Executive Vice President
2015-01-01

brent-hatzis-schoch_image

Brent Hatzis-Schoch
Brent Hatzis-Schoch COO and General Counsel @ Black Diamond Therapeutics
COO and General Counsel

Founder


alexander-mayweg_image

Alexander Mayweg

david-m-epstein_image

David M. Epstein

elizabeth-buck_image

Elizabeth Buck

Stock Details


Company's stock symbol is NASDAQ:BDTX

Investors List

nextech-invest_image

Nextech Invest

Nextech Invest investment in Series C - Black Diamond Therapeutics

bvf-partners_image

BVF Partners

BVF Partners investment in Series C - Black Diamond Therapeutics

logos-capital_image

Logos Capital

Logos Capital investment in Series C - Black Diamond Therapeutics

perceptive-advisors_image

Perceptive Advisors

Perceptive Advisors investment in Series C - Black Diamond Therapeutics

invus_image

Invus

Invus investment in Series C - Black Diamond Therapeutics

wellington-management_image

Wellington Management

Wellington Management investment in Series C - Black Diamond Therapeutics

versant-ventures_image

Versant Ventures

Versant Ventures investment in Series C - Black Diamond Therapeutics

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Series C - Black Diamond Therapeutics

roche-venture-fund_image

Roche Venture Fund

Roche Venture Fund investment in Series C - Black Diamond Therapeutics

city-hill-ventures_image

City Hill Ventures

City Hill Ventures investment in Series C - Black Diamond Therapeutics

Official Site Inspections

http://www.blackdiamondtherapeutics.com Semrush global rank: 3.73 M Semrush visits lastest month: 3.67 K

  • Host name: cloudhost-10606077.us-midwest-2.nxcli.net
  • IP address: 199.189.225.244
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Black Diamond Therapeutics"

Black Diamond Therapeutics, Inc. - AnnualReports.com

Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery of small molecule, tumor-agnostic therapies. Black …See details»

Black Diamond Therapeutics - Crunchbase Investor Profile

Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers. Black Diamond Therapeutics reported its first quarter 2024 financial results and …See details»

Black Diamond Therapeutics, Inc. (BDTX) - Yahoo Finance

See the company profile for Black Diamond Therapeutics, Inc. (BDTX) including business summary, industry/sector information, number of employees, business summary, corporate …See details»

Black Diamond Therapeutics - LinkedIn

Black Diamond Therapeutics is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations, expanding the addressable patient …See details»

Black Diamond Therapeutics - Overview, News & Similar

May 9, 2024 Black Diamond Therapeutics contact info: Phone number: (617) 252-0848 Website: www.blackdiamondtherapeutics.com What does Black Diamond Therapeutics do? Black …See details»

Black Diamond Therapeutics Company Overview, Contact Details ...

Jun 29, 2023 blackdiamondtherapeutics.com. SIC Code 8733 - Noncommercial Research Organizations. Stock Symbol BDTX. NAICS Code 541714 - Research and Development in …See details»

Press Release - Black Diamond Therapeutics, Inc.

Jun 13, 2023 Black Diamond Therapeutics is a clinical-stage precision oncology medicine company focused on the development of MasterKey therapies that target families of oncogenic …See details»

Press Release - Black Diamond Therapeutics, Inc.

Dec 31, 2020 “2020 was a pivotal year for Black Diamond with key progress made across our organization,” said David M. Epstein, Ph.D., President and Chief Executive Officer of Black …See details»

Black Diamond Therapeutics - CEO Roundtable

Black Diamond Therapeutics is a precision oncology medicine company pioneering the development of novel MasterKey therapies. Black Diamond is addressing the significant unmet …See details»

Black Diamond Therapeutics Company Profile - Craft

Oct 29, 2024 Black Diamond Therapeutics is a biotechnology company. It is focused on the development of selective medicines for patients with genetically-defined cancers driven by …See details»

Company Description - Stock Analysis

Black Diamond Therapeutics, Inc., a clinical-stage oncology medicine company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors.See details»

Black Diamond Therapeutics - PitchBook

Sep 10, 2021 Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The …See details»

Black Diamond Therapeutics - Overview, News & Similar

Jun 13, 2023 Black Diamond Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update CAMBRIDGE, Mass. and NEW YORK, May 09, 2023 (GLOBE …See details»

Black Diamond Therapeutics - VentureRadar

"Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery of small molecule, tumor-agnostic therapies. Black Diamond targets undrugged mutations in …See details»

Press Release - investors.blackdiamondtherapeutics.com

Oct 7, 2024 Black Diamond Therapeutics is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer.See details»

Press Release - investors.blackdiamondtherapeutics.com

Apr 17, 2023 Black Diamond Therapeutics is a clinical-stage precision oncology medicine company focused on the development of MasterKey therapies that target families of oncogenic …See details»

Black Diamond Therapeutics - Work in biotech

Black Diamond Therapeutics is developing small molecule therapies to meet the unmet need for precision oncology. Cancer is a genetic disease of which many are caused by mutations in …See details»

Press Release - investors.blackdiamondtherapeutics.com

Jan 10, 2022 Black Diamond Therapeutics is a precision oncology medicine company pioneering the development of novel MasterKey therapies. Black Diamond is addressing the significant …See details»

Press Release - Black Diamond Therapeutics, Inc.

Dec 31, 2021 Black Diamond Therapeutics is a precision oncology medicine company pioneering the development of novel MasterKey therapies. Black Diamond is addressing the …See details»

Press Release - investors.blackdiamondtherapeutics.com

Sep 21, 2021 Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery of MasterKey therapies. Black Diamond targets undrugged mutations …See details»

linkstock.net © 2022. All rights reserved